IL6 and hepatocellular carcinoma: In hepatocellular carcinoma (HCC), CAFs that overexpress IL-6 can induce strong immunosuppression in the TME by recruiting immunosuppressive cells such as bone marrow-derived suppressor cells and can impair the function of tumor-infiltrating T cells by upregulating suppressive immune checkpoints (27).